Eugene has over 20 years’ experience in strategic commercialization and marketing, with expertise in digital strategy, product management and business development. He is equally adept in prescriber and healthcare professional strategies, as he is in patient and caregiver strategies. He has held positions at ICC Lowe as Chief Digital Officer, SVP of Product Management at ConnectiveRx and most recently Managing Director at Real Chemistry prior to joining ER in 2021.
Eugene leads our Consulting practice where he will set the strategy for the practice, maximize the value of our services to clients, advance our market reputation as thought leaders through creation and delivery of high value content, be a trusted advisor to our clients, and lead our new business development efforts.
Kate Miller Named Chief Strategy Officer at Evolution Road
Kate Miller has been promoted to the position of Chief Strategy Officer from the position of Digital Innovation/Commercialization Practice Lead. She has been with the firm for nearly 14 years and was previously the Vice President of Strategy. Kate will be responsible for ER’s market vision, positioning and branding, thought leadership and intellectual property.
August 30, 2021
Announcing Decoding Digital Health for Life Sciences
The ER team is pleased to invite you to a new industry event called Decoding Digital Health for Life Sciences, running June 15-16, 2021. This event will help Life Science brand and commercial teams better understand the digital health opportunity and how to leverage digital health to improve patient outcomes and drive commercial success. Decoding Digital Health was co-created by Evolution Road and ER's own Paul Ivans & Todd Kolm are the conference co-chairs.
April 20, 2021
Using big data to boost engagement, conversion and revenue
One of the country’s largest pharmaceutical companies and a top health information technology company had always wanted to work together, yet the right opportunity never presented itself. Taking an independent, objective view, we found one driven by data.
With the objective of driving awareness and education across an entire portfolio and, ultimately, incremental treatment rates and improved patient outcomes, we layered multiple data sources to inform a multi-pronged digital communications strategy that reached three million patients and drove $40 million in incremental revenue.
March 23, 2021
Reimagining patient engagement
A multinational pharmaceutical manufacturer knew there was room to improve engagement and adherence amongst its diabetes patients.
Where standard approaches fell short, we created the digital strategy, guided program development and piloted a multi-touch engagement program designed to meet patients on their terms—with deep personalization and less friction.
March 23, 2021
Eliminating care gaps through digital innovation
One of the world’s top pharmaceutical companies sought to narrow gaps in care across its entire vaccine portfolio.
Cultivating a collaborative partnership for our client with CareSpeak, an OptimizeRx company that offers an interactive health messaging platform, we crafted a comprehensive member communications strategy that sparked measurable, meaningful engagement.
March 22, 2021
Telemedicine is here to stay: How the barriers are breaking down
Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.
February 3, 2021
Realizing the Promise of Digital Health Partnerships
Why have commercial life sciences, with a track record of going it alone, pivoted to partnerships with the Digital Health Ecosystem? How might a life science marketer get their organization primed for more/better partnering? How is the success of a partnership measured? What are some of the key watchouts in partnering?
December 18, 2020